Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Lynn M. Malec MD

Lynn M. Malec MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Publications (16)

  • Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database. (Roberts JC, Malec LM, Halari I, Hale SA, Oladapo A, Sidonio RF Jr) Haemophilia 2022 Jan;28(1):97-108 PMID: 34761486 PMCID: PMC9299176 SCOPUS ID: 2-s2.0-85118846443 11/12/2021       4 Citations
  • Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A. (Ebbert PT, Xavier F, Malec LM, Seaman CD, Ragni MV) Thromb Res 2020 Nov;195:51-54 PMID: 32653601 SCOPUS ID: 2-s2.0-85087678383 07/13/2020       6 Citations
  • The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United States. (Malec LM, Cheng D, Witmer CM, Jaffray J, Kouides PA, Haley KM, Sidonio RF Jr, Johnson K, Recht M, White G, Croteau SE, Ragni MV) Am J Hematol 2020 Aug;95(8):960-965 PMID: 32356313 SCOPUS ID: 2-s2.0-85087914846 05/02/2020       15 Citations
  • Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: A survey of select US haemophilia treatment centres. (Malec LM, Croteau SE, Callaghan MU, Sidonio RF Jr) Haemophilia 2020 May;26(3):e128-e129 PMID: 32142196 SCOPUS ID: 2-s2.0-85080877418 03/07/2020       16 Citations
  • Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia. (Croteau SE, Cheng D, Cohen AJ, Holmes CE, Malec LM, Silvey M, Thornburg CD, Wheeler AP, Kouides PA, Raffini LJ, Neufeld EJ) Haemophilia 2019 Jul;25(4):668-675 PMID: 30993845 SCOPUS ID: 2-s2.0-85064708024 04/18/2019       34 Citations
  • Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome. (Malec LM, Cooper J, Rudolph J, Michaels MG, Ragni MV) J Pediatr Gastroenterol Nutr 2018 Jun;66(6):972-975 PMID: 29135819 SCOPUS ID: 2-s2.0-85048199342 11/15/2017       6 Citations
  • Feasibility of the Von Willebrand disease PREVENT trial. (Ragni MV, Machin N, James AH, Seaman CD, Malec LM, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brooks MM) Thromb Res 2017 Aug;156:8-13 PMID: 28577390 SCOPUS ID: 2-s2.0-85020021120 06/04/2017       10 Citations
  • Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center. (Leeper CM, Vissa M, Cooper JD, Malec LM, Gaines BA) Pediatr Blood Cancer 2017 Aug;64(8) PMID: 28067012 SCOPUS ID: 2-s2.0-85008487831 01/10/2017       36 Citations
  • Extended half-life factor VIII for immune tolerance induction in haemophilia. (Malec LM, Journeycake J, Ragni MV) Haemophilia 2016 Nov;22(6):e552-e554 PMID: 27640873 SCOPUS ID: 2-s2.0-84995962587 09/20/2016       26 Citations
  • Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein. (Ragni MV, Alabek M, Malec LM) Haemophilia 2016 Sep;22(5):e462-4 PMID: 27501368 SCOPUS ID: 2-s2.0-84990177338 08/09/2016       9 Citations
  • Von Willebrand factor for menorrhagia: a survey and literature review. (Ragni MV, Machin N, Malec LM, James AH, Kessler CM, Konkle BA, Kouides PA, Neff AT, Philipp CS, Brambilla DJ) Haemophilia 2016 May;22(3):397-402 PMID: 26843404 PMCID: PMC4874860 SCOPUS ID: 2-s2.0-84957712009 02/05/2016       37 Citations
  • Validation Study of the Composite Score to Identify Von Willebrand Disease in Children. (Malec LM, Moore CG, Bennett CM, Yee DL, Kerlin BA, Witmer CM, Kulkarni R, Gupta S, Gunawardena S, Kouides PA, Brown D, Ragni MV) J Pediatr Hematol Oncol 2016 Mar;38(2):139-42 PMID: 26535774 SCOPUS ID: 2-s2.0-84959568636 11/05/2015       10 Citations
  • Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction. (Ragni MV, DiMichele DM, Hay CM, Malec LM, Seaman CD, Li J, Yabes JG, Butenas S, Brummel-Ziedins K) Haemophilia 2016 Mar;22(2):240-247 PMID: 26517283 SCOPUS ID: 2-s2.0-84960391929 10/31/2015       3 Citations
  • Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database. (Malec LM, Moore CG, Yabes J, Li J, Ragni MV) Haemophilia 2015 Sep;21(5):e442-5 PMID: 26189327 SCOPUS ID: 2-s2.0-84942196574 07/21/2015       16 Citations
  • Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance. (Ragni MV, Malec LM) Expert Rev Hematol 2014 Dec;7(6):747-55 PMID: 25374055 PMCID: PMC4356531 SCOPUS ID: 2-s2.0-84911430479 11/07/2014       18 Citations
  • Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophilia. (Malec LM, Sidonio RF Jr, Smith KJ, Cooper JD) J Pediatr Hematol Oncol 2014 Aug;36(6):474-9 PMID: 25054457 SCOPUS ID: 2-s2.0-84905015377 07/24/2014       4 Citations
  • Last update: 01/08/2023